Identification of a unique gene expression signature that differentiates hepatocellular adenoma from well-differentiated hepatocellular carcinoma

被引:20
作者
Chen, ZME
Crone, KG
Watson, MA
Pfeifer, JD
Wang, HL
机构
[1] Washington Univ, Sch Med, Dept Pathol & Immunol, Lauren V Ackerman Lab Surg Pathol, St Louis, MO 63110 USA
[2] Washington Univ, Sch Med, Dept Pathol & Immunol, Div Lab Med, St Louis, MO 63110 USA
关键词
hepatocellular adenoma; hepatocellular carcinoma; gene expression microarray;
D O I
10.1097/01.pas.0000176426.21876.a5
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
It is often difficult to distinguish hepatocellular adenoma (HCA) from well-differentiated hepatocellular carcinoma (WDHCC) when limited tissue from a needle biopsy is evaluated. The aim of this study was to identify gene expression patterns that can distinguish HCA from WDHCC, with the ultimate goal of discovering novel diagnostic markers. Gene expression profile analysis was performed using Aftymetrix U133PIus2 GeneChip microarrays on RNA isolated from frozen tissue of 6 HCA and 8 WDHCC specimens. Statistical analysis of microarray data identified 63 genes whose expression levels were significantly different between HCA and WDHCC. These included 57 genes overexpressed by HCA and 6 overexpressed by WDHCC. Eight genes were chosen for further analysis by quantitative RT-PCR on RNA derived from archived, paraffin-embedded tissue blocks of an independent validation set comprising 9 HCAs and 9 HCCs. Seven of the 8 genes demonstrated average expression differences between HCA and HCC that were concordant with the microarray findings, and their expression pattern correctly classified the 18 tumors into HCA and HCC using unsupervised clustering analysis. Furthermore, immunohistochemical staining performed on a third, independent set of 27 HCAs and 33 HCCs confirmed the expression differences at protein levels for 5 of the genes. Taken together, our data demonstrate significant molecular differences between HCA and WDHCC, despite their morphologic similarity. More importantly, we have identified a unique set of genes whose expression pattern can discriminate between these two types of hepatocellular neoplasms, suggesting the possibility of future development of ancillary molecular and immunohistochemical diagnostic methods.
引用
收藏
页码:1600 / 1608
页数:9
相关论文
共 41 条
[1]   CLONING AND SEQUENCE OF THE HUMAN NUCLEAR-PROTEIN CYCLIN - HOMOLOGY WITH DNA-BINDING PROTEINS [J].
ALMENDRAL, JM ;
HUEBSCH, D ;
BLUNDELL, PA ;
MACDONALDBRAVO, H ;
BRAVO, R .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (06) :1575-1579
[2]  
ANTHONY PP, 2002, PATHOLOGY LIVER, P713
[3]   Epidemiology of primary liver cancer [J].
Bosch, FX ;
Ribes, J ;
Borràs, J .
SEMINARS IN LIVER DISEASE, 1999, 19 (03) :271-285
[4]   Molecular profiling of human hepatocellular carcinoma defines mutually exclusive interferon regulation and insulin-like growth factor II overexpression [J].
Breuhahn, K ;
Vreden, S ;
Haddad, R ;
Beckebaum, S ;
Stippel, D ;
Flemming, P ;
Nussbaum, T ;
Caselmann, WH ;
Haab, BB ;
Schirmacher, P .
CANCER RESEARCH, 2004, 64 (17) :6058-6064
[5]  
CARIANI E, 1988, CANCER RES, V48, P6844
[6]   Sex and androgenic steroid receptor expression in hepatic adenomas [J].
Cohen, C ;
Lawson, D ;
DeRose, PB .
HUMAN PATHOLOGY, 1998, 29 (12) :1428-1432
[7]  
de Boer WB, 2000, CANCER CYTOPATHOL, V90, P273, DOI 10.1002/1097-0142(20001025)90:5<273::AID-CNCR2>3.0.CO
[8]  
2-M
[9]   EXPRESSION OF INSULIN-LIKE GROWTH-FACTOR-II (IGF-II) IN HUMAN HEPATOCELLULAR CARCINOMAS - AN IMMUNOHISTOCHEMICAL STUDY [J].
DERRICO, A ;
GRIGIONI, WF ;
FIORENTINO, M ;
BACCARINI, P ;
LAMAS, E ;
DEMITRI, S ;
GOZZETTI, G ;
MANCINI, AM ;
BRECHOT, C .
PATHOLOGY INTERNATIONAL, 1994, 44 (02) :131-137
[10]   Rising incidence of hepatocellular carcinoma in the United States [J].
El-Serag, HB ;
Mason, AC .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (10) :745-750